October 12, 2022 | Fierce BioTech

Ascidian Therapeutics rises from ATP’s ocean floor with $50M and Dyne’s former CEO

October 12, 2022 | EndPoints News

Michael Ehlers and Romesh Subramanian launch biotech with $50M, sea squirt-inspired RNA-editing tech

October 12, 2022 | BOSTON BUSINESS JOURNAL

Dyne founder heads up new RNA-editing startup

October 12, 2022 | BIOWORLD

Ascidian closes $50M financing to rewrite the rules of RNA splicing

October 12, 2022 | BIOSPACE

Ascidian Nets $50M to Rewrite RNA in Stargardt Disease and Beyond

October 12, 2022 | BIOPHARMA DIVE

Ascidian starts up with $50M and a twist on RNA editing

October 12, 2022 | BIOCENTURY

Ascidian: correcting mutations via trans-splicing to edit RNA exons